Drug Discovery Solutions

  1. Surfactant Analysis Services
    4/17/2019

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  2. Lonza: CDMO Offerings Span Complete Biopharma Product Lifecycle
    4/17/2019

    Ibex Solutions, from Lonza, consist of three innovative CDMO offerings that span the complete product lifecycle of a biopharmaceutical – from preclinical to commercial stages, from drug substance to drug product, all in one location. 

  3. Container Closure Integrity Testing
    4/17/2019

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  4. Viral Therapy Contract Manufacturing Services: Relevant Industry Experience
    4/17/2019

    Lonza is committed to working closely with our customers to provide cost-effective and time-efficient solutions for their development and manufacturing needs. Read more about our complete service including process development, GMP manufacturing of drug substances, aseptic fill/finish of drug product, product release testing, regulatory support and cGMP storage and distribution.

  5. Light Pathâ„¢ Custom Material Supply: Mammalian And Microbial Custom Services For Protein Production
    4/17/2019

    At Lonza, we understand the challenges facing biotherapeutic and vaccine manufacturers related to the time and costs inherent in the drug discovery and development process. Light Path™ Custom Material Supply Services are efficient, focused technology and production offerings for the Preclinical and Phase I stages of novel biologics development.

  6. More Shots On Goal Using A Developability Assessment Tool
    7/5/2018

    Data-driven risk assessment enables smart decisions on development strategy.

  7. Mammalian Cell Culture: Process R&D Services
    4/17/2019

    Lonza’s global R&D center for mammalian cell processes is based in Slough, UK alongside a custom manufacturing facility. Lonza undertakes highly specialized development and manufacturing services for the pharmaceutical and biotechnology industries. Read more about Lonza’s complete range of R&D Services and an array of technologies and skills to best match their customers’ requirements for all stages of product development.

  8. Integrated Biotech Services: From Strain To Commercial Product
    4/17/2019

    Backed by Lonza’s more than 30 years’ expe­rience and expertise in biological processing and our track record in the chemical and bio­technological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.

  9. Particle Control In Biopharmaceuticals
    4/17/2019

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.